PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

World-first discovery uncovers how glioblastoma tumours dodge chemotherapy, potentially opening the door to new treatments

Researchers will now work with industry to progress the discovery toward drug development for future testing

2025-12-15
(Press-News.org)

World-first research published today by University of Sydney scientists has uncovered a mechanism that may explain why glioblastoma returns after treatment, offering new clues for future therapies which they will now investigate as part of an Australian industry collaboration. 

 

Glioblastoma is one of the deadliest brain cancers, with a median survival rate of just 15 months. Despite surgery and chemotherapy, more than 1250 clinical trials over the past 20 years have struggled to improve survival rates.

 

Published in Nature Communications, the study shows that a small population of drug-tolerant cells known as “persister cells” rewires its metabolism to survive chemotherapy, using an unexpected ally as an invisibility cloak: a fertility gene called PRDM9.

 

“This is a world-first discovery that changes what we know about glioblastoma,” said lead author Professor Lenka Munoz from the Charles Perkins Centre at the University of Sydney. “By uncovering how these cancer cells recruit a fertility gene to survive treatment, we’ve opened the door to new approaches that we hope could lead to safer, more effective therapies.”

 

The researchers are now working with Australian biotech company Syntara to develop PRDM9 inhibitors for further testing in animal models, with the hope to eventually progress to human studies. The next steps are to determine whether these inhibitors can eliminate persister cells and prevent glioblastoma from returning. Trialling this in humans is likely several years away, pending successful completion of preclinical safety and efficacy studies. 

 

Accounting for about half of all brain tumours, glioblastoma claims the lives of up to 200,000 people globally and around 1000 Australians each year. Even after surgery, radiation and chemotherapy, recurrence is almost universal. Clinicians call this “minimal residual disease”, meaning the few hidden cancer cells that survive treatment eventually regrow the tumour. 

 

“For patients and their families facing glioblastoma, recurrence is inevitable. This research offers hope for new strategies in the future where none existed,” said Professor Munoz, who co-led the study with Dr George Joun from the School of Medical Sciences in the Faculty of Medicine and Health.

 

How glioblastoma uses a fertility gene to cheat chemotherapy

 

The researchers found that while the body undergoes chemotherapy stress, glioblastoma cells are able to hijack PRDM9 to churn out cholesterol, helping persister cells withstand damage and eventually allowing the tumour to return. Previously, PRDM9 was only known as a fertility gene, active in reproductive cells at the very start of egg and sperm formation, long before fertilisation. 

 

“Chemotherapy kills most cancer cells, but in glioblastoma a few survive and are able to regrow the tumour. We think we’ve found their survival trick and potential ways to block it,” said Professor Munoz. 

 

Researchers hope new treatment strategy could prevent glioblastoma relapse

 

By blocking PRDM9 or cutting off cholesterol supply, researchers were able to wipe out persister cells in lab and animal models. When combined with chemotherapy, their approach dramatically improved survival in mice. 

 

The team also developed a new brain-penetrant chemotherapy drug, WJA88, and paired it with a cholesterol-lowering agent already tested in humans. This combination shrank tumours and extended survival in preclinical models with minimal side effects. 

 

“PRDM9 isn’t active in most normal tissues, which makes it an incredibly selective and promising target for cancer therapy,” said Dr Joun, first author and Research Fellow in the School of Medical Sciences. “If we can eliminate the last cancer cells standing, we can stop glioblastoma from returning. That would be a game changer for patients and families.”

 

Potential implications for other hard-to-treat cancers

 

The researchers say this is the first time PRDM9 has been linked to cancer, potentially opening the door to safer, more targeted treatments. Professor Munoz and her team believe the same mechanism may exist in other hard to treat cancers, with plans to test the approach on ovarian cancer next.

 

“Cancer relapse is one of the biggest challenges in oncology. Our research shows that by directly targeting persister cells, relapse may be preventable in preclinical models,” said Professor Munoz.

 

Experts hope the discovery could reshape cancer research and treatment globally.

 

“We now need to look beyond the bulk of the tumour and study rare persister cells that drive recurrence, as well as what happens after treatment ends rather than only during drug exposure,” said Professor Munoz.

-ENDS-

END



ELSE PRESS RELEASES FROM THIS DATE:

A fatal mix-up: How certain gut bacteria drive multiple sclerosis

2025-12-15
If gut bacteria are too similar to the protective layer of nerves, they can misdirect the immune system and cause it to attack its own nervous system. This mechanism can accelerate the progression of multiple sclerosis, as researchers at the University of Basel have shown in trials with mice. However, their results also open up opportunities for treatments that make use of the microbiome. When the immune system confuses friend and foe, autoimmune diseases develop. In the case of multiple sclerosis (MS), it mistakenly attacks the body’s protective layer of nerve fibers, known as the myelin sheath. Those affected can experience exhaustion ...

New AI tool identifies not just genetic mutations, but the diseases they may cause

2025-12-15
New York, NY [December 15, 2025] —Scientists at the Icahn School of Medicine at Mount Sinai have developed a novel artificial intelligence tool that not only identifies disease-causing genetic mutations but also predicts the type of disease those mutations may trigger. The method, called V2P (Variant to Phenotype), is designed to accelerate genetic diagnostics and aid in the discovery of new treatments for complex and rare diseases. The findings were reported in the December 15 online issue of Nature Communications [DOI: 10.1038/s41467-025-66607-w]. Current genetic analysis tools can estimate whether a mutation is harmful, but they cannot determine ...

Deep-learning model predicts how fruit flies form, cell by cell

2025-12-15
During early development, tissues and organs begin to bloom through the shifting, splitting, and growing of many thousands of cells.  A team of MIT engineers has now developed a way to predict, minute by minute, how individual cells will fold, divide, and rearrange during a fruit fly’s earliest stage of growth. The new method may one day be applied to predict the development of more complex tissues, organs, and organisms. It could also help scientists identify cell patterns that correspond to early-onset diseases, such as ...

Combination pills for high blood pressure may simplify treatment, improve long-term health

2025-12-15
Statement Highlights: Single-pill medications that combine two or more blood pressure medications could simplify treatment to help more adults with high blood pressure achieve target blood pressure levels faster and maintain blood pressure goals long-term compared with patients taking multiple, separate pills daily. The use of combination medications is linked to a lower risk of heart attack, stroke, heart failure-related hospitalizations and death, as well as to improved quality of life and reduced long-term costs for patients and the health care system. More research is needed to understand the impact of single-pill combination medications for people with higher cardiovascular risks ...

Immune system keeps mucosal fungi in check

2025-12-15
The microbiome not only consists of bacteria, but also of fungi. Most of them support human and animal health. However, some fungi also have pathogenic potential. For instance, the yeast Candida albicans can grow in an uncontrolled manner on the oral mucosa, causing oral thrush. In severe cases by growing in a filamentous form it can enter the blood stream and cause systemic infections, which account for over one million deaths per year. This happens primarily in people with a weakened immune system on intensive care units, for instance individuals who are immunosuppressed ...

Neurons within the brain use simple rules to localize genetic messages

2025-12-15
Scientists found that messenger RNA (mRNA) molecules that carry genetic instructions to the far reaches of neurons in the brain tend to cluster together mostly because they are abundant, not because they move in coordinated groups. The discovery, published in the Society for Neuroscience journal eNeuro, helps explain how neurons, which have some of the longest processes of any cells in the body, manage genetic instructions long distances from where they are made.  This fundamental process is critical to support neuronal communication and the modifications ...

Electrodes created using light

2025-12-15
Visible light can be used to create electrodes from conductive plastics completely without hazardous chemicals. This is shown in a new study carried out by researchers at Linköping and Lund universities, Sweden. The electrodes can be created on different types of surfaces, which opens up for a new type of electronics and medical sensors. “I think this is something of a breakthrough. It’s another way of creating electronics that is simpler and doesn’t require any expensive equipment,” says Xenofon Strakosas, assistant professor at the Laboratory of Organic Electronics, LOE, at Linköping University. LOE’s researchers are working with ...

Second-hand gift-giving is a well-deliberated decision

2025-12-15
Fair price, treasure hunting, i.e., the thrill of finding something rare or valuable, as well as ethical and ecological reasons motivate consumers’ intentions to buy second-hand gifts, a recent study from the University of Eastern Finland finds. Administered to users of one of Finland’s most popular consumer-to-consumer online marketplaces, Tori.fi, the survey also shows that an intention to buy a second-hand gift often leads to an actual purchase decision. “Our findings indicate that buying second-hand gifts is a well-thought-through decision rather than an impulsive one. It involves the ...

How human interaction drove evolution to make bears less aggressive

2025-12-15
A new paper in Molecular Biology and Evolution, published by Oxford University Press, reports that Italian bears living in areas with many villages evolved and became smaller and less aggressive. Humans have long shaped the environments in which they live, dramatically affecting ecosystems and biodiversity. Habitat change and overuse are among the human activities with the greatest impacts on wildlife, often leading to population declines and/or shifts in selective pressures, thus influencing how a species evolves. The Apennine brown bear, Ursus arctos marsicanus, is a small and isolated population found only in ...

National Poll: Few parents offer teens guidance on healthy eating during holiday season

2025-12-15
ANN ARBOR, Mich. – As teens gain more independence in their food choices, many parents struggle to navigate conversations about nutrition —which could be especially important during the holidays, when celebrations often center around meals. While parents recognize concerns about their teen’s eating habits, few provide concrete strategies to help them make healthy decisions during festive gatherings, according to the University of Michigan Health C.S. Mott Children’s Hospital National Poll on Children’s Health. One in three parents say it’s difficult to talk with their teen about food and weight, rising ...

LAST 30 PRESS RELEASES:

YouTubers love wildlife, but commenters aren't calling for conservation action

New study: Immune cells linked to Epstein-Barr virus may play a role in MS

AI tool predicts brain age, cancer survival, and other disease signals from unlabeled brain MRIs

Peak mental sharpness could be like getting in an extra 40 minutes of work per day, study finds

No association between COVID-vaccine and decrease in childbirth

AI enabled stethoscope demonstrated to be twice as efficient at detecting valvular heart disease in the clinic

Development by Graz University of Technology to reduce disruptions in the railway network

Large study shows scaling startups risk increasing gender gaps

Scientists find a black hole spewing more energy than the Death Star

A rapid evolutionary process provides Sudanese Copts with resistance to malaria

Humidity-resistant hydrogen sensor can improve safety in large-scale clean energy

Breathing in the past: How museums can use biomolecular archaeology to bring ancient scents to life

Dementia research must include voices of those with lived experience

Natto your average food

Family dinners may reduce substance-use risk for many adolescents

Kumamoto University Professor Kazuya Yamagata receives 2025 Erwin von Bälz Prize (Second Prize)

Sustainable electrosynthesis of ethylamine at an industrial scale

A mint idea becomes a game changer for medical devices

Innovation at a crossroads: Virginia Tech scientist calls for balance between research integrity and commercialization

Tropical peatlands are a major source of greenhouse gas emissions

From cytoplasm to nucleus: A new workflow to improve gene therapy odds

Three Illinois Tech engineering professors named IEEE fellows

Five mutational “fingerprints” could help predict how visible tumours are to the immune system

Rates of autism in girls and boys may be more equal than previously thought

Testing menstrual blood for HPV could be “robust alternative” to cervical screening

Are returning Pumas putting Patagonian Penguins at risk? New study reveals the likelihood

Exposure to burn injuries played key role in shaping human evolution, study suggests

Ancient American pronghorns were built for speed

Two-stage hydrothermal process turns wastewater sludge into cleaner biofuel

Soil pH shapes nitrogen competition between wheat and microbes, new study finds

[Press-News.org] World-first discovery uncovers how glioblastoma tumours dodge chemotherapy, potentially opening the door to new treatments
Researchers will now work with industry to progress the discovery toward drug development for future testing